Mauldin v. 3M Company

CourtDistrict Court, N.D. California
DecidedFebruary 4, 2021
Docket5:20-cv-07212
StatusUnknown

This text of Mauldin v. 3M Company (Mauldin v. 3M Company) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mauldin v. 3M Company, (N.D. Cal. 2021).

Opinion

A TRUE COPY ‘A ATIEST: ROBIN L. BLUME, CLERK BY: dl. = Shea,

DEPUTY CLERK UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION

IN RE: AQUEOUS FILM-FORMING FOAMS PRODUCTS LIABILITY LITIGATION MDL No. 2873

TRANSFER ORDER

Before the Panel:* Plaintiffs in the three actions listed on Schedule A move under Panel Rule 7.1 to vacate our orders that conditionally transferred their respective actions to the District of South Carolina for inclusion in MDL No. 2873. Defendants Tyco Fire Products, LP, and Chemguard, Inc., oppose all three motions. Defendant 3M Company opposes the motions brought by the Mauldin and Poynter-Abell plaintiffs. Defendants Dawn Chemical Corporation of Wisconsin, Inc., and Royal Chemical Company, Ltd., oppose the motion brought by plaintiffs in the Nessel action. In support of their motions to vacate, plaintiffs in all three actions argue that federal subject matter jurisdiction over their respective actions is lacking, and that their pending motions for remand to state court should be decided before transfer. The Panel has held that such jurisdictional objections generally do not present an impediment to transfer.' See, e.g., In re Prudential Ins. Co. of Am. Sales Practices Litig., 170 F. Supp. 2d 1346, 1347-48 (J.P.M.L. 2001). Plaintiffs can present their remand arguments to the transferee court. Plaintiffs in the Mauldin and Poynter-Abell actions also argue that transfer of their actions is inappropriate because they do not involve allegations of groundwater contamination. Rather, plaintiffs allege that they are or were firefighters who were exposed to per- or polyfluoroalkyl substances (PFAS) through use of aqueous film-forming foams (AFFFs), which are used to extinguish fires, and by wearing certain protective clothing and gear that allegedly contained PFAS. Plaintiffs thus argue that their actions do not involve the same factual core as the actions pending in MDL No. 2873.

* Judge David C. Norton did not participate in the decision of this matter. ' Panel Rule 2.1(d) expressly provides that the pendency of a conditional transfer order does not limit the pretrial jurisdiction of the court in which the subject action is pending. Between the date a remand motion is filed and the date that transfer of the action to the MDL is finalized, a court generally has adequate time to rule on a remand motion if it chooses to do so. Indeed, the transferor court in the Western District of Michigan Nessel action denied plaintiffs’ remand motion on January 6, 2021.

- 2 -

Plaintiffs are correct that our transfer orders in this docket to date have involved allegations that AFFFs used at airports, military bases, or other locations to extinguish liquid fuel fires caused the release of perfluorooctane sulfonate (PFOS) and/or perfluorooctanoic acid (PFOA, both of which are types of PFAS) into local groundwater and contaminated drinking water supplies. Plaintiffs also are correct that we have been cautious to avoid unnecessarily expanding this MDL to encompass non-AFFF products. See, e.g., Order Denying Transfer at 1–2, MDL No. 2873 (J.P.M.L. Mar. 27, 2020), ECF No. 620 (declining to transfer eight actions that did not allege injury from AFFF use). Even so, MDLs can naturally expand to encompass other claims involving the products at issue and presenting similar factual questions. See, e.g., In re Gen. Motors LLC Ignition Switch Litig., MDL No. 2543, 2014 WL 5597269, at 1 n.1 (J.P.M.L. Oct. 22, 2014) (“While MDL No. 2543 initially included only actions asserting economic damages, it has been expanded to include personal injury and wrongful death actions.”). This is such an instance. The “direct exposure” claims in Mauldin and Poynter-Abell share several important factual questions with the groundwater contamination cases in MDL No. 2873. Both sets of cases involve factual questions concerning the toxicity of PFOA and PFOS and their effects on human health; the chemical properties of these substances; the knowledge of the AFFF manufacturers regarding the dangers of PFOA and PFOS; their warnings, if any, regarding proper use and storage of AFFFs; and to what extent, if any, defendants conspired or cooperated to conceal the dangers of PFOA and PFOS in their products. Centralization of these direct exposure claims thus will eliminate duplicative discovery and prevent inconsistent pretrial rulings (including with respect to discovery, privilege, and Daubert motion practice). Moreover, the parties do not dispute that MDL No. 2873 already includes more than 350 direct exposure actions by firefighters that were filed directly in the transferee court. At least one firefighter action was transferred by the Panel through the conditional transfer order process without opposition. The plaintiff fact sheet used in the MDL for personal injury claims contains questions regarding direct exposure and use of AFFF products. See Case Mgmt. Order No. 5, Ex. 1, at 3–4, In re Aqueous Film-Forming Foams Prods. Liab. Litig., C.A. No. 2:18-mn-02873 (D.S.C. Aug. 7, 2019), ECF No. 205 (asking whether “you [have] ever been employed, trained as, or volunteered as a firefighter” and requesting specifics about the use of AFFFs, training provided, and the protective equipment worn”). Transfer of the direct exposure claims in Mauldin and Poynter-Abell thus will not inhibit the efficiency of the pretrial proceedings in the MDL.2 Plaintiffs argue that their claims differ from the firefighter claims in the MDL because plaintiffs focus on the alleged harm stemming from the firefighters’ protective equipment. Even if we accept this characterization (which defendants dispute), Mauldin and Poynter-Abell still 2 Plaintiffs argue that we should discount the pendency of the direct exposure actions in the MDL because neither the Panel nor the transferee court has yet had to resolve any opposition to including these cases in the MDL. The problem with this argument is that, were we to decline to transfer Mauldin and Poynter-Abell, there would still be a large mass of direct exposure cases in the MDL. Denying transfer would only ensure that multiple courts would have to address the common factual issues and pretrial proceedings presented by these actions. - 3 -

involve allegations that the use of AFFFs to extinguish fires caused plaintiffs’ injury. “Section 1407 does not require a compete identity or even majority of common factual issues as a prerequisite to transfer.” In re Ins. Brokerage Antitrust Litig., 360 F. Supp. 2d 1371, 1372 (J.P.M.L. 2005). Finally, plaintiffs insist that transfer will cause them inconvenience and prejudice, as many of the firefighter plaintiffs are retired and elderly, and many, if not most, of plaintiffs’ witnesses are located in California and Missouri. This argument is not persuasive. Centralization under Section 1407 is for pretrial proceedings only, and there usually is no need for parties or witnesses to travel to the transferee court for depositions or court hearings. See In re MLR, LLC, Patent Litig., 269 F. Supp. 2d 1380, 1381 (J.P.M.L. 2003). In any event, transfer of an action is appropriate if it furthers the expeditious resolution of the litigation taken as a whole, even if some parties to the action might experience inconvenience or delay. See In re Watson Fentanyl Patch Prods. Liab. Litig., 883 F. Supp. 2d 1350, 1351–52 (J.P.M.L. 2012) (“[W]e look to the overall convenience of the parties and witnesses, not just those of a single plaintiff or defendant in isolation.”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Prudential Ins. Co. of America Sales Pract.
170 F. Supp. 2d 1346 (Judicial Panel on Multidistrict Litigation, 2001)
In Re MLR, LLC, Patent Litigation
269 F. Supp. 2d 1380 (Judicial Panel on Multidistrict Litigation, 2003)
In Re Insurance Brokerage Antitrust Litigation
360 F. Supp. 2d 1371 (Judicial Panel on Multidistrict Litigation, 2005)
In re Aqueous Film-Forming Foams Prods. Liab. Litig.
357 F. Supp. 3d 1391 (Judicial Panel on Multidistrict Litigation, 2018)
In re Watson Fentanyl Patch Products Liability Litigation
883 F. Supp. 2d 1350 (Judicial Panel on Multidistrict Litigation, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Mauldin v. 3M Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mauldin-v-3m-company-cand-2021.